Elon Musk threatened to drop the evidence that Donald Trump fears most, according to one of the president's biographers.The pair publicly split Thursday and quickly fell into a bitter feud online, and the tech billionaire escalated the conflict by posting that he would "drop the really big bomb" wit...

ALT: a cat is sitting on a bed with its legs crossed and looking at the camera .

DNA inherited from Neandertals may influence modern human cognition

Skeletal muscle fat infiltration (IMAT) is linked to coronary microvascular dysfunction and increased cardiovascular risk, independent of BMI and traditional risk factors.

Oprah Winfrey has shared the surprising discovery she made about "thin people" due to her experience with Ozempic.

He used the constitution to shatter the constitution. January 08, 2025 Ninety-two years ago this month , on Monday morning, January 30, 1933, Adolf Hitler was appointed the 15th chancellor of the Weim...

How GLP-1 therapies could help build a healthier, more productive workforce—and what that would mean for how we live together.

President-elect Trump’s threat to tariff Denmark if it resists his acquisition plans for the island territory of Greenland could disrupt one export that is wildly popular in America: Ozempic.…

More than 1 billion people worldwide live with obesity and almost two-thirds of deaths are attributed to non-communicable disease.

None.

This link will take you to a page that’s not on LinkedIn

YouTube video by The Plus SideZ: Cracking the Obesity Code

Pulitzer Prize Winner Looks at Race in America from a Different Angle

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear whether Trump's administration will see it through.

Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors.

Vivani's groundbreaking NanoPortal™ technology enters clinical testing, promising twice-yearly GLP-1 administration to potentially rival semaglutide's efficacy in obesity treatment.

TikTok video by Weighofthebuddha

Insurers deny tens of millions of claims every year. ProPublica is investigating why claims are denied, what the consequences are for patients and how the appeal process really works.